| Name | Title | Contact Details |
|---|---|---|
Ashley Vasilovski |
Vice President, Business Applications, IT | Profile |
David Regt |
VP Engineering, Platform | Profile |
Venu Venugopal |
Chief Technology Officer | Profile |
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Maintenance Assistant is one of the fastest growing cloud-based Enterprise Asset Management (EAM) and CMMS solution providers. Using cutting-edge design and technology, Maintenance Assistant develops and delivers maintenance software solutions that are used by thousands of asset-intensive businesses around the world to transform their maintenance operations, eliminate waste and costly downtime, and manage risk. Our robust technology platform enables our partners to build innovative cloud and mobile CMMS solutions for their customers, and participate in the on-going maintenance-related revenues associated with the products and equipment they sell.
bConvergent is a Rockville, MD-based company in the Software and Internet sector.
Clearspeed™ voice analytics technology provides unique risk alerts based on an individual’s vocal responses.
CADopia is a San Diego, CA-based company in the Software and Internet sector.